Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tema Healthcare AI ETF (NQ:HLTH)

26.68 -0.05 (-0.19%)
Delayed Quote Updated: 10:13 AM EST, Nov 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Tema Healthcare AI ETF

< Previous 1 2 Next >
News headline image
Tema Launches Healthcare AI ETF (HLTH)
From Tema ETFs
Via Business Wire
News headline image
Cue Health to Pursue Wind Down of the Business
From Cue Health Inc.
Via Business Wire
News headline image
Cue Health Evaluating Warning Letter Received from Food and Drug Administration (FDA)
From Cue Health Inc.
Via Business Wire
News headline image
Cue Health to Announce First Quarter Financial Results
From Cue Health Inc.
Via Business Wire
News headline image
Cue Health Announces Strategic Actions to Position Company for Next Stage
From Cue Health Inc.
Via Business Wire
News headline image
Cue Health Reports Fourth Quarter 2023 Financial Results
From Cue Health Inc.
Via Business Wire
News headline image
Cue Health to Announce Fourth Quarter and Full Year 2023 Financial Results
From Cue Health Inc.
Via Business Wire
News headline image
Cue Health Announces Appointment of Rishi Reddy to Board of Directors
From Cue Health Inc.
Via Business Wire
News headline image
Cue Health to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Cue Health Inc.
Via Business Wire
News headline image
Cue Health Reports Third Quarter 2023 Financial Results
From Cue Health Inc.
Via Business Wire
News headline image
Cue Health to Announce Third Quarter 2023 Financial Results
From Cue Health Inc.
Via Business Wire
News headline image
Concerned Stockholders of Cue Health Send Letter to Board
From On behalf of Concerned Stockholders of Cue Health
Via Business Wire
News headline image
Peer-Reviewed Independent Study Published in Microbiology Spectrum Finds Cue Health’s Molecular COVID-19 Test is as Accurate as a Lab-Based PCR Test
From Cue Health
Via Business Wire
News headline image
Cue Health Adopts Limited-Duration Shareholder Rights Plan
From Cue Health Inc.
Via Business Wire
News headline image
Cue Health to Present at Upcoming Investor Conferences
From Cue Health Inc.
Via Business Wire
News headline image
Cue Health Reports Second Quarter 2023 Financial Results
From Cue Health Inc.
Via Business Wire
News headline image
Cue Health Awarded New $28 Million Federal Contract to Develop Flu A/B, RSV, COVID-19 Molecular Multiplex Test for Both Over-the-Counter and Point-of-Care Use
From Cue Health Inc.
Via Business Wire
News headline image
Cue Health to Announce Second Quarter 2023 Financial Results
From Cue Health Inc.
Via Business Wire
News headline image
Cue Health Achieves Groundbreaking Milestone with FDA: First Company to Receive De Novo Authorization for a COVID-19 Home Use Test
From Cue Health
Via Business Wire
News headline image
Cue Health to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
From Cue Health Inc.
Via Business Wire
News headline image
Cue Health Reports First Quarter 2023 Financial Results
From Cue Health Inc.
Via Business Wire
News headline image
Cue Health Makes De Novo Submission to FDA for Full Clearance of its Cue® RSV Molecular Test
From Cue Health
Via Business Wire
News headline image
Cue Health Launches Pharmacy Offering to Empower Individuals to Manage Common Health and Wellness Needs from Home
From Cue Health
Via Business Wire
News headline image
Cue Health to Announce First Quarter 2023 Financial Results
From Cue Health Inc.
Via Business Wire
News headline image
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Cue Health Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cue Health Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
Cue Health Receives FDA Emergency Use Authorization for Molecular Mpox Test
From Cue Health
Via Business Wire
News headline image
Cue Health Reports Fourth Quarter and Full-Year 2022 Financial Results
From Cue Health Inc.
Via Business Wire
News headline image
Cue Health’s New Suite of At-Home Diagnostic Tests and Expansion of Cue Care Puts You in Control of Your Health
From Cue Health
Via Business Wire
News headline image
Cue Health Collaborates with Pfizer to Provide People who Test Positive for COVID-19 with Actionable Health Information to Better Inform their Treatment Journey
From Cue Health
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.